#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 Doctor in our hospital is using this intelligent system for accurate diagnosis

Doctor in our hospital is using this intelligent system for accurate diagnosis. (Photo: Business Wire)


March 31, 2020 — The Intelligent Evaluation System of chest computed tomography (CT) for COVID-19, developed by YITU under the guidance of Shanghai Public Health Clinical Center, was officially launched and was put into the first-line battle against COVID-19 pandemic on Jan. 28. It is the first AI-equipped diagnostic assistant, which significantly improves efficiency in identifying coronavirus through automatic detection and quantitative analysis within 2-3 seconds, and eases the burden of Chinese doctors.

YITU Healthcare reinforced its R&D capability with multi-departments cooperation right after the outbreak of the pandemic and released its cutting-edge AI diagnosis system, with upgrades on a daily basis during the Chinese New Year. YITU assisted many designated medical institutions and supported the frontline heroes fighting the pandemic.

According to its official public account of Shanghai Public Health Clinical Center, one of the authoritative institutions in the field of infectious diseases in China and the key unit for the treatment of COVID-19 in Shanghai, an article titled "AI Aids the Scientific Prevention and Control, Intelligent Evaluation System for COVID-19 Launched in Shanghai Public Health Clinical Center", announced its latest achievements in using artificial intelligence technology to help doctors carry out quantitative analysis and evaluation of therapeutic efficacy of new coronavirus lesions based on CT images.

COVID-19 Diagnosis and Treatment Plan (Trial Version 7) issued by the General Office of the National Health Commission of the People's Republic of China stipulates that CT imaging results should be used as one of the criteria for the diagnosis of COVID-19 nationwide. At the same time, based on clinical experience, the CT imaging performance of COVID-19 is further clarified and the quantitative evaluation of CT images is incorporated into the clinical classification basis.

YITU's AI-driven solution of intelligent diagnosis and quantitative evaluation of CT images of COVID-19, are through industry-leading image algorithms, and grade the severity of various pneumonia diseases of local lesions, diffuse lesions, and whole lung involvement. Furthermore, it accurately quantifies the cumulative pneumonia load of the disease through quantitative and omics analysis of key image features such as the morphology, range, and density of the lesion, and achieves a dynamic 4-D contrast of the lung lesions on the CT, helping in clinical judgment of the condition, evaluation of the efficacy, and prediction of the prognosis.

Taking up the challenge and responsibility in response to frontline needs and requests, YITU's Intelligent Evaluation System of Chest CT for COVID-19 has been adopted across 25 provinces and municipal autonomous prefectures in 100 medical institutions and served over 100,000 person-times in China by far.

For more information: www.yitutech.com

Related Coronavirus Content:

VIDEO: Use of Telemedicine in Medical Imaging During COVID-19

VIDEO: How China Leveraged Health IT to Combat COVID-19

 CDRH Issues Letter to Industry on COVID-19

Qure.ai Launches Solutions to Help Tackle COVID19 

ASRT Deploys COVID-19 Resources for Educational Programs

Study Looks at CT Findings of COVID-19 Through Recovery

VIDEO: Imaging COVID-19 With Point-of-Care Ultrasound (POCUS)

The Cardiac Implications of Novel Coronavirus

CT Provides Best Diagnosis for Novel Coronavirus (COVID-19)

Radiology Lessons for Coronavirus From the SARS and MERS Epidemics

Deployment of Health IT in China’s Fight Against the COVID-19 Epidemic

Emerging Technologies Proving Value in Chinese Coronavirus Fight

Radiologists Describe Coronavirus CT Imaging Features

Coronavirus Update from the FDA

CT Imaging of the 2019 Novel Coronavirus (2019-nCoV) Pneumonia

CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV)

Chest CT Findings of Patients Infected With Novel Coronavirus 2019-nCoV Pneumonia 

Find more related clinical content Coronavirus (COVID-19)


Related Content

News | Innovative Hospitals

July 27, 2026 — Vanderbilt Health and Siemens Healthineers have entered into a multi-year, $87 million Value ...

Time July 28, 2026
arrow
News | Computed Tomography (CT)

July 23, 2026 — HOPPR has introduced HOPPR EF Chest CT Narrative Model, a foundation model that processes 3D chest CT ...

Time July 27, 2026
arrow
News | Pediatric Imaging

July 17, 2026 — In June, UW Health Kids began welcoming patients into a new state-of-the-art imaging suite dedicated to ...

Time July 23, 2026
arrow
News | Information Technology

July 20, 2026 — GE HealthCare has introduced MIM Anyware, a remote access platform that provides secure, healthcare ...

Time July 20, 2026
arrow
News | Radiation Oncology

July 16, 2026 — Raidium has announced the U.S. launch of Raidium Read (R.Read), applying its AI-native imaging solution ...

Time July 16, 2026
arrow
Feature | Information Technology | Kyle Hardner

Artificial intelligence (AI) has enhanced diagnostic accuracy and improved triage in radiology. But far fewer tools ...

Time July 16, 2026
arrow
News | ACR

July 15, 2026 — The American College of Radiology (ACR) recently issued a statement praising the inclusion of the ...

Time July 16, 2026
arrow
News | Cardiac Imaging

July 8, 2026 — Conavi Medical Corp. has announced the publication of a case report in the Journal of the Society for ...

Time July 15, 2026
arrow
News | PET Imaging

July 14, 2026 — New research is shedding new light on the biological basis of schizophrenia by directly measuring ...

Time July 15, 2026
arrow
News | Ultrasound Imaging

July 7, 2026 — Longeviti Neuro Solutions has launched a new strategic initiative, ClearFit AI, a Brain Ultrasound ...

Time July 09, 2026
arrow
Subscribe Now